August 30, 2025 – September 3, 2025, Lisbon Portugal | Booth #435
August 30, 2025 – September 3, 2025, Lisbon Portugal | Booth #435
BOSTON, March 04, 2025 (GLOBE NEWSWIRE) — Praxis Precision Medicines, Inc. (NASDAQ: PRAX), a clinical-stage biopharmaceutical company translating genetic insights into the development of therapies for central nervous system (CNS) disorders characterized by neuronal excitation-inhibition imbalance, today announced that it will be participating in five upcoming investor conferences:
| Date and Time (PT) | Poster Number | Poster Title | Poster Session |
|---|---|---|---|
| Saturday, April 511:45 AM – 12:45 PM | 5-011 Neighborhood 5 |
Spotlight on Essential Tremor Management and Impact: Results from an Online Survey Capturing HCP and Patient Perspectives of Disease Burden | P1: Movement Disorders: Essential Tremor and Other Tremor Disorders |
| Saturday, April 511:45 AM – 12:45 PM | 5-012 Neighborhood 5 |
Characteristics of Adult Essential Tremor Patients Seeking Participation in a Decentralized US Clinical Trial: Pre-screener Findings from the Essential3 Program Evaluating Efficacy and Safety of Ulixacaltamide | P1: Movement Disorders: Essential Tremor and Other Tremor Disorders |
| Monday, April 78:00 AM – 9:00 AM | 9-012 Neighborhood 9 |
Epilepsy Monitoring of Prospective Seizure Observations with Electronic Records (EMPOWER): An Observational Study Designed to Better Understand the Patient Journey | P5: Epilepsy/Clinical Neurophysiology (EEG): Neuromodulation Devices and Seizure Tracking |
| Wednesday, April 98:00 AM – 9:00 AM | 4-006 Neighborhood 4 |
Updates from the First-in-human Phase 1 Clinical Trial Evaluating the Safety, Tolerability, Pharmacokinetics and Food Effect of Vormatrigine in Healthy Participants | P11: Emerging Science |
NYU Langone Comprehensive Epilepsy Center, NY
NYU Langone Comprehensive Epilepsy Center, NY
Loma Linda University School of Medicine, CA
Cincinnati College of Medicine, OH
Praxis Precision Medicines, MA
| Time | Speaker | Presentation Title |
|---|---|---|
| 1:30 pm – 1:50 pm | Dr. Alberto Espay | Essential Tremor: Hidden Burden and Current Treatment Challenges |
| Question/Answer Time | ||
| 2:00 pm – 2:20 pm | Dr. Jacqueline French | EMPOWER: An Observational Study Designed to Better Understand the Patient Journey in Epilepsy |
| Question/Answer Time | ||
| 2:30 pm – 2:50 pm | Dr. Monique Giroux | Ulixacaltamide: The Journey to Develop a New Essential Tremor Therapy |
| Question/Answer Time | ||
| 3:00 pm – 3:20 pm | Dr. Jacqueline French | EMPOWER: An Observational Study Designed to Better Understand the Patient Journey in Epilepsy |
| Question/Answer Time | ||
| 3:30 pm Adjournment | ||
| Time | Speaker | Presentation Title |
|---|---|---|
| 1:30 pm – 1:50 pm | Dr. Alberto Espay | Essential Tremor: Hidden Burden and Current Treatment Challenges |
| Question/Answer Time | ||
| 2:00 pm – 2:20 pm | Dr. Jacqueline French | EMPOWER: An Observational Study Designed to Better Understand the Patient Journey in Epilepsy |
| Question/Answer Time | ||
| 2:30 pm – 2:50 pm | Dr. Monique Giroux | Ulixacaltamide: The Journey to Develop a New Essential Tremor Therapy |
| Question/Answer Time | ||
| 3:00 pm – 3:20 pm | Dr. Orrin Devinsky | Maximizing Impact on Disease and the Future of Treatment for Epilepsy |
| Question/Answer Time | ||
| 3:30 pm Adjournment | ||
| Time | Speaker | Presentation Title |
|---|---|---|
| 1:30 pm – 1:50 pm | Dr. Kashayar Dashtipour | Essential Tremor: Hidden Burden and Current Treatment Challenges |
| Question/Answer Time | ||
| 2:00 pm – 2:20 pm | Dr. Orrin Devinsky | Maximizing Impact on Disease and the Future of Treatment for Epilepsy |
| Question/Answer Time | ||
| 2:30 pm – 2:50 pm | Dr. Monique Giroux | Ulixacaltamide: The Journey to Develop a New Essential Tremor Therapy |
| Question/Answer Time | ||
| 3:00 pm – 3:20 pm | Dr. Orrin Devinsky | Maximizing Impact on Disease and the Future of Treatment for Epilepsy |
| Question/Answer Time | ||
| 3:30 pm Adjournment | ||
| Time | Speaker | Presentation Title |
|---|---|---|
| 1:30 pm – 1:50 pm | Dr. Kashayar Dashtipour | Essential Tremor: Hidden Burden and Current Treatment Challenges |
| Question/Answer Time | ||
| 2:00 pm – 2:20 pm | Dr. Monique Giroux | Ulixacaltamide: The Journey to Develop a New Essential Tremor Therapy |
| Question/Answer Time | ||
| 2:30 pm Adjournment | ||
| Day 1 – Sunday April 6 | ||
| Time | Presenter | Presentation Title (TBC) |
|---|---|---|
| 1:30 pm - 1:50 pm | Dr. Alberto Espay | Lorem ipsum dolor sit amet adipiscing aleum nonsectetur alit deu alis presentum lorem dolor sit amet. |
| Question/Answer Time | ||
| 2:00 pm - 2:20 pm | Dr. Jacqueline French | Lorem ipsum dolor sit amet adipiscing aleum nonsectetur alit deu alis presentum lorem dolor sit amet. |
| Question/Answer Time | ||
| 2:30 pm - 2:50 pm | Dr. Monique Giroux | Lorem ipsum dolor sit amet adipiscing aleum nonsectetur alit deu alis presentum lorem dolor sit amet. |
| Question/Answer Time | ||
| 3:00 pm - 3:20 pm | Dr. Jacqueline French | Lorem ipsum dolor sit amet adipiscing aleum nonsectetur alit deu alis presentum lorem dolor sit amet. |
| Question/Answer Time | ||
| 3:30 pm Adjournment | ||
99 High Street
30th Floor
Boston, Massachusetts 02110